The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma

The management of metastatic renal cell carcinoma (mRCC) continues to be a therapeutic challenge; however, the options for systemic therapy in this setting have exploded over the past 20 years. From the advent of toxic cytokine therapy to the subsequent discovery of targeted therapy (TT) and immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Umbreit, Eric C., McIntosh, Andrew G., Suk-Ouichai, Chalairat, Karam, Jose A., Wood, Christopher G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033221/
https://www.ncbi.nlm.nih.gov/pubmed/33850351
http://dx.doi.org/10.4103/iju.IJU_293_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033221/
https://www.ncbi.nlm.nih.gov/pubmed/33850351
http://dx.doi.org/10.4103/iju.IJU_293_20

Ejemplares similares